Home » Labopharm Meets With FDA to Discuss Second Approvable Letter for Once-Daily Tramadol
Labopharm Meets With FDA to Discuss Second Approvable Letter for Once-Daily Tramadol
Labopharm announced that it has met with the U.S. Food and Drug Administration (FDA) to discuss the matters raised in the Agency’s May 30, 2007 Approvable Letter for the Company’s once-daily formulation of tramadol.
Labopharm
Upcoming Events
-
07May
-
14May
-
30May